Inspire Medical Systems Inc. (INSP): A Technical View

0
4

As of Wednesday close, Inspire Medical Systems Inc.’s (NYSE:INSP) stock was up $2.25, moving up 1.00 percent to $227.26. The average number of shares traded per day over the past five days has been 307,400 shares. 5 times new highs have been achieved over the past 5 days, with a $11.58 gain in that time frame. In the last twenty days, the average volume was 388,005, while in the previous 50 days, it was 330,308.

Since last month, INSP stock rose 25.52%. Shares of the company fell to $171.32 on 10/24/22, the lowest level in the past month. A 52-week high of $272.04 was reached on 04/04/22 after having rallying from a 52-week low of $142.74. Since the beginning of this year, INSP’s stock price has dropped by -1.22% or -$2.80, and marked a new high 7 times. However, the stock has declined by -16.46% since its 52-week high.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


INSP stock investors should be aware that Inspire Medical Systems Inc. (INSP) stock had its last reported insider trading activity 13 days ago on Nov 11. Griffin Jerry C, the Director of the company, disposed of 9,217 shares for $221.42 on Nov 11. It resulted in a $2,040,853 divestment by the insider. Buchholz Richard sold 15,000 shares at an average price of $258.67 on Apr 01. The insider now owns 47,176 shares following the transaction. On Apr 01, Director NELSON MARILYN C sold 10,000 shares at $267.50 apiece. The transaction was valued at $2,675,000.

Valuation Metrics

The stock’s beta is 1.51. Besides these, the trailing price-to-sales (P/S) ratio of 18.98, the price-to-book (PB) ratio of 13.64.

Financial Health

In the three months ended June 29, Inspire Medical Systems Inc.’s quick ratio stood at 9.70, while its current ratio was 10.10, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 84.20% percent. In the year ended June 29, operating margins totaled -14.10%. Based on annual data, INSP earned $200.12 million in gross profit and brought in $233.39 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -15.70%. Return on equity (ROE) for the past 12 months was -17.50%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. INSP’s revenue rose 43.5% to $91.39 million during the quarter, while net income inched up to $109.19 million. While analysts expected Inspire Medical Systems Inc. to report -$0.62 quarterly earnings, the actual figure was -$0.53 per share, beating the consensus estimate by 14.50%. During the quarter, the company generated -$16.68 million in EBITDA. The liabilities of Inspire Medical Systems Inc. were 57.32 million at the end of its most recent quarter ended June 29, and its total debt was $31.34 million. The value of shareholders’ equity is $28.89 million.

Technical Picture

This quick technical analysis looks at Inspire Medical Systems Inc.’s (INSP) price momentum. With a historical volatility rate of 29.19%, the RSI 9-day stood at 74.51% on 23 November.

With respect to its five-day moving average, the current Inspire Medical Systems Inc. price is up by +5.37% percent or $11.58. At present, INSP shares trade +24.12% above its 20-day simple moving average and +13.06% percent above its 100-day simple moving average. However, the stock is currently trading approximately +10.79% above its SMA50 and -2.76% below its SMA200.

Stochastic coefficient K was 78.58% and Stochastic coefficient D was 68.58%, while ATR was 10.21. Given the Stochastic reading of 91.27% for the 14-day period, the RSI (14) reading has been calculated as 70.02%. As of today, the MACD Oscillator reading stands at 5.84, while the 14-day reading stands at 9.43.

Analyst Ratings

Truist launched its rating on Inspire Medical Systems Inc. (NYSE: INSP) to a Buy in a note to investors on April 13, 2022. Inspire Medical Systems Inc. (INSP) has been rated Overweight by analysts. According to 0 brokerage firms, INSP is a sell, and 3 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Inspire Medical Systems Inc. stock as buy, with 9 recommending it as overweight.

With a median target price of $270.00, the current consensus forecast for the stock is $245.00 – $305.00. Based on these forecasts, analysts predict Inspire Medical Systems Inc. (INSP) will achieve an average price target of $272.22.

LEAVE A REPLY

Please enter your comment!
Please enter your name here